Market revenue in 2023 | USD 102.0 million |
Market revenue in 2030 | USD 140.5 million |
Growth rate | 4.7% (CAGR from 2023 to 2030) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | Freestyle Lite |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Accu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip |
Key market players worldwide | Roche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 20.1% in 2023. Horizon Databook has segmented the Italy point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.
Italy has witnessed a significant increase in the number of people suffering from diabetes over the years. Currently, over 3 million people are suffering from diabetes in the country. According to the International Diabetes Federation, this number is expected to increase to approximately 5 million by 2030.
Presence of well-established glucose POC diagnostics manufacturers help in effectively managing diabetes. For instance, The Menarini Group is a pharmaceutical manufacturer located in Italy and has a separate division, Menarini Diagnostics, which is fully dedicated to diagnostic products.
The company offers glucometers such as Glucofix Premium, which quantifies glucose and ketones at the same time. This was designed to reduce the risk of ketoacidosis in diabetic patients. The introduction of such glucose meters in the market is expected to fuel the demand for POC glucose testing products in Italy.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Italy point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account